James Mulshine, MD

In this video at ASCO 2018, James Mulshine, MD, discusses CMS coverage of low-dose CT lung cancer screening for selected Medicare beneficiaries, and clinical implications of early detection.

This excellent, concise review of the status of lung cancer chemoprevention complements a benchmark review of the whole field of chemoprevention by Drs. Benner, Lippman, Hong and colleagues that appeared recently in the Journal of Clinical Oncology [1] Careful scrutiny of both these articles yields a number of issues for consideration.